Product Information
CLONAZEPAM 1 MG ODT is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.5546 per EA under NDC 62332036706. Its NADAC has been published 353 times since Nov 20, 2019.
FDA first approved this application on Jun 28, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332036706
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA211033FDA Approved
6/28/2019
TE Code
AB
On Market Since
7/1/2019
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 1 MG ODT has been published 353 times since Nov 20, 2019, and over the history we have for it it has declined 9.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5546 per EA |
|---|---|
| All-time high | $0.8553 (Mar 16, 2022) |
| All-time low | $0.4241 (Mar 22, 2023) |
| 52-week high | $0.5921 |
| 52-week low | $0.4879 |
| Median price | $0.6508 |
| Average price | $0.6518 |
| Largest weekly change | +48.7% (Jun 19, 2024) |
| Weeks tracked | 353 |
| Tracking since | Nov 20, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CLONAZEPAM market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLONAZEPAM 1 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 1 MG ODT, manufactured by Alembic Pharmaceuticals Inc., is $0.5546 per EA (NDC 62332036706), effective Aug 19, 2026.
How has the price of CLONAZEPAM 1 MG ODT changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 1 MG ODT has declined 9.7%. It has been tracked across 353 weekly CMS publications since Nov 20, 2019.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 1 MG ODT?
Since Nov 20, 2019, the NADAC for CLONAZEPAM 1 MG ODT has ranged from a low of $0.4241 (Mar 22, 2023) to a high of $0.8553 (Mar 16, 2022), with a median of $0.6508 per EA.
Are there cheaper alternatives to CLONAZEPAM 1 MG ODT?
No other NADAC-published product currently shares the active ingredient and strength of CLONAZEPAM 1 MG ODT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLONAZEPAM 1 MG ODT?
CLONAZEPAM 1 MG ODT (NDC 62332036706) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.